Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Nanovaccines: A game changing approach in the fight against infectious diseases

Open access
Priyanka, Abusalah, Mai Abdel Haleem, Chopra, Hitesh, Sharma, Abhilasha, Mustafa, Suhad Asad, Choudhary, Om Prakash, Sharma, Manish, Dhawan, Manish, Khosla, Rajiv, Loshali, Aanchal, Sundriyal, Ankush, Saini, Jyoti · 2023 · Biomedicine & Pharmacotherapy

Abstract

The field of nanotechnology has revolutionised global attempts to prevent, treat, and eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a valuable pawn in this novel technology. Nanovaccines are made up of nanoparticles that are associated with or prepared with components that can stimulate the host's immune system. In addition to their delivery capabilities, the nanocarriers have been demonstrated to possess intrinsic adjuvant properties, working as immune cell stimulators. Thus, nanovaccines have the potential to promote rapid as well as long-lasting humoral and cellular immunity. The nanovaccines have several possible benefits, including site-specific antigen delivery, increased antigen bioavailability, and a diminished adverse effect profile. To avail these benefits, several nanoparticle-based vaccines are being developed, including virus-like particles, liposomes, polymeric nanoparticles, nanogels, lipid nanoparticles, emulsion vaccines, exomes, and inorganic nanoparticles. Inspired by their distinctive properties, researchers are working on the development of nanovaccines for a variety of applications, such as cancer immunotherapy and infectious diseases. Although a few challenges still need to be overcome, such as modulation of the nanoparticle pharmacokinetics to avoid rapid elimination from the bloodstream by the reticuloendothelial system, The future prospects of this technology are also assuring, with multiple options such as personalised vaccines, needle-free formulations, and combination nanovaccines with several promising candidates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2023.115597

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 179

Metadata

Authors
Priyanka, Abusalah, M. A. H., Chopra, H., Sharma, A., Mustafa, S. A., Choudhary, O. P., Sharma, M., Dhawan, M., Khosla, R., Loshali, A., Sundriyal, A., & Saini, J.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2023-11
Volume
167
Pages
115597
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4387242295
Cited by
179
References
21
FWCI
15.69
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanovaccines: A game changing approach in the fight against infectious diseases. https://app.cochat.ai/papers/10.1016/j.biopha.2023.115597
The paper
Priyanka, Abusalah, M. A. H., Chopra, H., Sharma, A., Mustafa, S. A., Choudhary, O. P., Sharma, M., Dhawan, M., Khosla, R., Loshali, A., Sundriyal, A., & Saini, J. (2023). Nanovaccines: A game changing approach in the fight against infectious diseases. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2023.115597

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.